Evidence-based leaflet human papillomavirus (HPV) vaccination for pupils

ISRCTN ISRCTN86240771
DOI https://doi.org/10.1186/ISRCTN86240771
Secondary identifying numbers N/A
Submission date
31/01/2011
Registration date
25/03/2011
Last edited
30/06/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Anke Steckelberg
Scientific

Martin-Luther King Platz 6
Hamburg
20146
Germany

Email asteckelberg@uni-hamburg.de

Study information

Study designDouble-blind randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request the patient information
Scientific titleImpact of an evidence-based leaflet on 'risk knowledge' of human papillomavirus (HPV) vaccination in disadvantaged pupils: a randomised controlled trial
Study acronymHPV-Eva
Study objectivesEvidence-based patient information leads to better risk knowledge in human papillomavirus (HPV) vaccination compared to standard information.
Ethics approval(s)1. The Ministry of Education and Culture, 30/10/2009
2. The Ethics Committee in Hamburg, 11/01/2011, ref: PV3344
Health condition(s) or problem(s) studiedHuman papillomavirus (HPV) vaccination
InterventionIntervention: evidence-based patient information
Control treatment: standard patient information

Pupils received either the evidence-based leaflet or the standard one in the beginning of a 1.5 hour session.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Human papillomavirus (HPV) vaccination
Primary outcome measureRisk-knowledge, measured immediately after the intervention
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/01/2010
Completion date01/05/2010

Eligibility

Participant type(s)Patient
Age groupChild
SexFemale
Target number of participants94
Key inclusion criteriaParticipants were vocational school pupils who were preparing for grade 10 graduation and who were members of the target group for HPV vaccination.
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/01/2010
Date of final enrolment01/05/2010

Locations

Countries of recruitment

  • Germany

Study participating centre

Martin-Luther King Platz 6
Hamburg
20146
Germany

Sponsor information

University of Hamburg (Germany)
University/education

Martin-Luther King Platz 6
Hamburg
20146
Germany

Email asteckelberg@uni-hamburg.de
Website http://www.uni-hamburg.de/
ROR logo "ROR" https://ror.org/04bs1pb34

Funders

Funder type

University/education

University of Hamburg (Germany) - paid the salary of the PI

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 17/10/2013 Yes No